The Spearman analysis showed that CDH1, CTNNB1 were significantly relevant with tumour sizes (p = 0.03) and clinical stage (p < 0.001) not age (p = 0.461), gender (p = 0.335), smoking (p = 0.224). This evidence concerns the gene CDH1 and neoplasm.